Significant advancements in pharmaceutical regulation and medical research, ranging from new weight loss drug approvals to breakthroughs in infectious disease prevention.

The UK has become the first European nation to approve the oral GLP-1 drug orforglipron for weight management and diabetes treatment.

New meta-analysis research suggests that GLP-1 receptor agonists may effectively reduce binge eating behaviors and emotional eating in individuals with obesity.

President Trump is set to sign an executive order aimed at increasing flexibility and research initiatives regarding vaccine policies.

A study indicates that a multicomponent meningococcal B vaccine provides modest protection against gonorrhea in high-burden teenage populations.

Researchers have linked reduced cardiac output to smaller brain volumes specifically in older adults who carry the APOE-e4 allele.

The Scottish Medicines Consortium has approved Acarizax as the first house dust mite immunotherapy treatment for persistent allergic rhinitis.

A report on HIV care in Missouri highlights that many patients frequently cycle in and out of treatment, complicating traditional retention strategies.

Recent discussions explore the legacy of cardiologist Eugene Braunwald, reflecting on his professional influence and concerns regarding the current state of US medicine.